v3.26.1
Accrued Liabilities
 6 Months Ended
Jun. 30, 2026
Accrued Liabilities, Current [Abstract]  
Accrued Liabilities Accrued Liabilities
Accrued liabilities as of June 30, 2026 and December 31, 2025 consisted of the following (in thousands):
 June 30,
2026		December 31,
2025
Rebates, returns and other revenue related reserves$152,272 $90,504 
Clinical study, manufacturing and drug supply
29,890 26,907 
Compensation and benefits46,124 69,211 
Selling, general and administrative57,911 40,026 
Other52,459 33,744 
Total accrued liabilities$338,656 $260,392